Galit Rosen

Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial

Manish R. Patel, John Ellerton, Jeffrey R. Infante et al. · The Lancet Oncology · 2017 · 588 citations · Full text

Medicine, Oncology, Urology +12

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

Ghayas C. Issa, Ibrahim Aldoss, John F. DiPersio et al. · Nature · 2023 · 468 citations · Full text

Medicine, Molecular Biology, Oncology +13

Invasive Fungal Infections in Pediatric Oncology Patients

Galit Rosen, Karin Nielsen, Sungching Glenn et al. · Journal of Pediatric Hematology/Oncology · 2005 · 157 citations

Medicine, Oncology, Pediatrics +11

Safety and Efficacy of Menin Inhibition in Patients (Pts) with MLL-Rearranged and NPM1 Mutant Acute Leukemia: A Phase (Ph) 1, First-in-Human Study of SNDX-5613 (AUGMENT 101)

Eytan M. Stein, Ibrahim Aldoss, John F. DiPersio et al. · Blood · 2021 · 55 citations

Medicine, Oncology, Pharmacology +13

Updated efficacy and safety of avelumab in metastatic urothelial carcinoma (mUC): Pooled analysis from 2 cohorts of the phase 1b Javelin solid tumor study.

Andrea B. Apolo, John Ellerton, Jeffrey R. Infante et al. · Journal of Clinical Oncology · 2017 · 36 citations

Medicine, Oncology, Pharmacology +16